Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
4.200
-0.060 (-1.41%)
At close: Jun 26, 2026, 4:00 PM EDT
4.160
-0.040 (-0.95%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Plus Therapeutics Employees
Plus Therapeutics had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$185,071
Profits / Employee
-$426,107
Market Cap
28.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Kyntra Bio | 34 |
| Actinium Pharmaceuticals | 25 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Serina Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
| NanoViricides | 7 |
PSTV News
- 3 days ago - Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - GlobeNewsWire
- 5 days ago - Plus Therapeutics to Provide Business Update Call on June 30, 2026 - GlobeNewsWire
- 23 days ago - Plus Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory - GlobeNewsWire
- 26 days ago - Plus Therapeutics Registration statement: Registration filing - Filings
- 26 days ago - Plus Therapeutics files $100M mixed securities shelf - TheFly
- 4 weeks ago - Plus announces presentation of health economics study on CNSide CSF assay - TheFly
- 4 weeks ago - Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases - GlobeNewsWire